Header Logo

Connection

Frances Lynch to Adolescent

Back to Details
This is a "connection" page, showing publications Frances Lynch has written about Adolescent.
Frances Lynch
Connection Strength
1.487
Adolescent
  1. Provider Perspectives on the Use of Mental Health Apps, and the BritePath App in Particular, With Adolescents at Risk for Suicidal Behavior: Qualitative Study. JMIR Hum Factors. 2025 Feb 26; 12:e64867.
    View in: PubMed
    Score: 0.134
  2. A framework for measuring the cost to families of caring for children's health: the design, methodology, and study population of the r-Kids study. BMC Pediatr. 2023 03 20; 23(1):128.
    View in: PubMed
    Score: 0.117
  3. Cost-effectiveness of Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care. JAMA Netw Open. 2021 03 01; 4(3):e211778.
    View in: PubMed
    Score: 0.102
  4. Evidence on the longitudinal construct validity of major generic and utility measures of health-related quality of life in teens with depression. Qual Life Res. 2018 02; 27(2):447-454.
    View in: PubMed
    Score: 0.081
  5. Measuring Health-related Quality of Life in Teens With and Without Depression. Med Care. 2016 Dec; 54(12):1089-1097.
    View in: PubMed
    Score: 0.076
  6. A primary care-based, multicomponent lifestyle intervention for overweight adolescent females. Pediatrics. 2012 Mar; 129(3):e611-20.
    View in: PubMed
    Score: 0.054
  7. Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findings. Arch Gen Psychiatry. 2011 Mar; 68(3):253-62.
    View in: PubMed
    Score: 0.051
  8. Estimating the economic burden of depression in children and adolescents. Am J Prev Med. 2006 Dec; 31(6 Suppl 1):S143-51.
    View in: PubMed
    Score: 0.038
  9. Cost-effectiveness of an intervention to prevent depression in at-risk teens. Arch Gen Psychiatry. 2005 Nov; 62(11):1241-8.
    View in: PubMed
    Score: 0.035
  10. Autism Diagnosis Among US Children and Adults, 2011-2022. JAMA Netw Open. 2024 Oct 01; 7(10):e2442218.
    View in: PubMed
    Score: 0.033
  11. Adolescents Who Do Not Endorse Risk via the Patient Health Questionnaire Before Self-Harm or Suicide. JAMA Psychiatry. 2024 Jul 01; 81(7):717-726.
    View in: PubMed
    Score: 0.032
  12. Clozapine Use Among People With Psychotic Disorders Who Experience Specific Indications for Clozapine. J Clin Psychiatry. 2024 Apr 29; 85(2).
    View in: PubMed
    Score: 0.032
  13. Impact of treatments for depression on comorbid anxiety, attentional, and behavioral symptoms in adolescents with selective serotonin reuptake inhibitor-resistant depression. J Am Acad Child Adolesc Psychiatry. 2013 May; 52(5):482-92.
    View in: PubMed
    Score: 0.029
  14. Reduction in avoidance mediates effects of brief behavioral therapy for pediatric anxiety and depression. Behav Res Ther. 2023 05; 164:104290.
    View in: PubMed
    Score: 0.029
  15. Using natural language processing to identify child maltreatment in health systems. Child Abuse Negl. 2023 Apr; 138:106090.
    View in: PubMed
    Score: 0.029
  16. Stepped care for suicide prevention in teens and young adults: Design and methods of a randomized controlled trial. Contemp Clin Trials. 2022 12; 123:106959.
    View in: PubMed
    Score: 0.028
  17. Brief Behavioral Therapy for Anxiety and Depression in Pediatric Primary Care: Breadth of Intervention Impact. J Am Acad Child Adolesc Psychiatry. 2023 02; 62(2):230-243.
    View in: PubMed
    Score: 0.028
  18. Detecting and distinguishing indicators of risk for suicide using clinical records. Transl Psychiatry. 2022 Jul 13; 12(1):280.
    View in: PubMed
    Score: 0.028
  19. Rising prevalence of antidepressants among US youths. Pediatrics. 2002 May; 109(5):721-7.
    View in: PubMed
    Score: 0.028
  20. What health records data are required for accurate prediction of suicidal behavior? J Am Med Inform Assoc. 2019 12 01; 26(12):1458-1465.
    View in: PubMed
    Score: 0.023
  21. The ReThink study: a 3-arm parallel randomized trial of cognitive bias modification, with and without adherence promotion, for adolescent anxiety disorder: trial design and protocol. BMC Psychiatry. 2019 10 22; 19(1):306.
    View in: PubMed
    Score: 0.023
  22. Patterns of Health Care Utilization Before First Episode Psychosis in Racial and Ethnic Groups. Ethn Dis. 2019; 29(4):609-616.
    View in: PubMed
    Score: 0.023
  23. Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care: A Follow-up. J Am Acad Child Adolesc Psychiatry. 2020 07; 59(7):856-867.
    View in: PubMed
    Score: 0.023
  24. Diagnosed Mental Health Conditions and Risk of Suicide Mortality. Psychiatr Serv. 2019 09 01; 70(9):750-757.
    View in: PubMed
    Score: 0.023
  25. Care Pathways Before First Diagnosis of a Psychotic Disorder in Adolescents and Young Adults. Am J Psychiatry. 2018 05 01; 175(5):434-442.
    View in: PubMed
    Score: 0.021
  26. Cost-effectiveness of Cognitive Behavioral Therapy for Depressed Youth Declining Antidepressants. Pediatrics. 2018 02; 141(2).
    View in: PubMed
    Score: 0.020
  27. Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care: A Randomized Clinical Trial. JAMA Psychiatry. 2017 06 01; 74(6):571-578.
    View in: PubMed
    Score: 0.020
  28. First Presentation With Psychotic Symptoms in a Population-Based Sample. Psychiatr Serv. 2017 May 01; 68(5):456-461.
    View in: PubMed
    Score: 0.019
  29. Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder. J Autism Dev Disord. 2017 Jan; 47(1):144-154.
    View in: PubMed
    Score: 0.019
  30. A Survey of Parents with Children on the Autism Spectrum: Experience with Services and Treatments. Perm J. 2017; 21:16-009.
    View in: PubMed
    Score: 0.019
  31. Cognitive Behavioral Therapy in Primary Care for Youth Declining Antidepressants: A Randomized Trial. Pediatrics. 2016 May; 137(5).
    View in: PubMed
    Score: 0.018
  32. Racial-Ethnic Differences in Psychiatric Diagnoses and Treatment Across 11 Health Care Systems in the Mental Health Research Network. Psychiatr Serv. 2016 07 01; 67(7):749-57.
    View in: PubMed
    Score: 0.018
  33. Health Services Utilization Among Children With and Without Autism Spectrum Disorders. J Autism Dev Disord. 2016 Mar; 46(3):910-20.
    View in: PubMed
    Score: 0.018
  34. Prevention of Depression in At-Risk Adolescents: Predictors and Moderators of Acute Effects. J Am Acad Child Adolesc Psychiatry. 2016 Mar; 55(3):219-26.
    View in: PubMed
    Score: 0.018
  35. Effect of a Cognitive-Behavioral Prevention Program on Depression 6 Years After Implementation Among At-Risk Adolescents: A Randomized Clinical Trial. JAMA Psychiatry. 2015 Nov; 72(11):1110-8.
    View in: PubMed
    Score: 0.018
  36. Validation of Autism Spectrum Disorder Diagnoses in Large Healthcare Systems with Electronic Medical Records. J Autism Dev Disord. 2015 Jul; 45(7):1989-96.
    View in: PubMed
    Score: 0.017
  37. Methodological considerations in service use assessment for children and youth with mental health conditions; issues for economic evaluation. Adm Policy Ment Health. 2015 May; 42(3):296-308.
    View in: PubMed
    Score: 0.017
  38. Racial/Ethnic differences in health care visits made before suicide attempt across the United States. Med Care. 2015 May; 53(5):430-5.
    View in: PubMed
    Score: 0.017
  39. Use of antipsychotic medications in pediatric populations: what do the data say? Curr Psychiatry Rep. 2013 Dec; 15(12):426.
    View in: PubMed
    Score: 0.015
  40. Prevention of depression in at-risk adolescents: longer-term effects. JAMA Psychiatry. 2013 Nov; 70(11):1161-70.
    View in: PubMed
    Score: 0.015
  41. Anhedonia predicts poorer recovery among youth with selective serotonin reuptake inhibitor treatment-resistant depression. J Am Acad Child Adolesc Psychiatry. 2012 Apr; 51(4):404-11.
    View in: PubMed
    Score: 0.014
  42. Services and prevention: pharmacoepidemiology of antidepressant use. Biol Psychiatry. 2001 Jun 15; 49(12):1121-7.
    View in: PubMed
    Score: 0.013
  43. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample. J Clin Psychiatry. 2011 Mar; 72(3):388-96.
    View in: PubMed
    Score: 0.013
  44. Prevention of depression in at-risk adolescents: a randomized controlled trial. JAMA. 2009 Jun 03; 301(21):2215-24.
    View in: PubMed
    Score: 0.011
  45. Health services use in eating disorders. Psychol Med. 2008 Oct; 38(10):1465-74.
    View in: PubMed
    Score: 0.010
  46. A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. J Am Acad Child Adolesc Psychiatry. 2005 Sep; 44(9):888-98.
    View in: PubMed
    Score: 0.009
  47. Patient-based utilities for bipolar disorder-related health states. J Affect Disord. 2005 Aug; 87(2-3):203-10.
    View in: PubMed
    Score: 0.009
  48. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med. 2003 Jan; 157(1):17-25.
    View in: PubMed
    Score: 0.007
  49. Group cognitive-behavioral treatment for depressed adolescent offspring of depressed parents in a health maintenance organization. J Am Acad Child Adolesc Psychiatry. 2002 Mar; 41(3):305-13.
    View in: PubMed
    Score: 0.007
  50. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry. 2001 Dec; 58(12):1127-34.
    View in: PubMed
    Score: 0.007

© 2025 Kaiser Permanente